Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 98001-98050 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04641026
Discovery of Biological Signatures for Cruciferous Vegetable Intake (Single Serving)
NA
Active, not recruiting
83 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04526119
A Phase III Trial of Z-338 in Paediatric Patients With Functional Dyspepsia
PHASE3
Recruiting
100 participants
Started: Feb 22, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04659707
Hyperpolarized 129Xe MRI of Survivors of COVID-19
PHASE1
Active, not recruiting
20 participants
Started: Feb 22, 2021 · Completed: May 1, 2025
1 condition
1 sponsor
1 location
NCT04054050
Bright Light Therapy for Sleep Disturbance in People With Multiple Sclerosis
NA
Enrolling by invitation
24 participants
Started: Feb 22, 2021 · Completed: Jan 30, 2026
1 condition
3 sponsors
1 location
NCT04564703
Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
PHASE2
Active, not recruiting
160 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2027
1 condition
3 sponsors
4 locations
NCT04567732
Bilateral Knee Osteoarthritis: Intra-articular Injection of Filtered Autologous Adipose Tissue Versus Placebo
NA
Active, not recruiting
100 participants
Started: Feb 22, 2021 · Completed: Apr 30, 2026
2 conditions
1 sponsor
1 location
NCT04735666
European TauroPace Registry - University of Schleswig-Holstein Prospective Observational Clinical Study
N/A
Recruiting
2,300 participants
Started: Feb 22, 2021 · Completed: Jan 30, 2030
1 condition
2 sponsors
8 locations
NCT04746235
Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia
PHASE2
Active, not recruiting
85 participants
Started: Feb 22, 2021 · Completed: Oct 31, 2026
3 conditions
1 sponsor
1 location
NCT04506853
Single-Sided Deafness and Asymmetric Hearing Loss
NA
Recruiting
65 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
6 locations
NCT04767165
Quantitative MRI of Bone Marrow in Patients With Acute Lymphoblastic Leukemia
NA
Recruiting
150 participants
Started: Feb 22, 2021 · Completed: Mar 21, 2026
1 condition
1 sponsor
1 location
NCT06979570
Personalized Performance Optimization Platform
NA
Recruiting
80 participants
Started: Feb 22, 2021 · Completed: Dec 30, 2025
5 conditions
2 sponsors
2 locations
NCT04276155
Management of Anticoagulant Therapy Monitored by an Implantable Device With Telecardiology in Patients With Acute Coronary Syndrome Associated With de Novo Atrial Fibrillation Arrhythmia
PHASE4
Recruiting
500 participants
Started: Feb 22, 2021 · Completed: Dec 1, 2024
1 condition
1 sponsor
8 locations
NCT04808037
Blmf, Lenalidomide and Dexamethasone in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
66 participants
Started: Feb 22, 2021 · Completed: Nov 8, 2028
1 condition
2 sponsors
1 location
NCT04729322
Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders
PHASE2
Active, not recruiting
15 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2025
7 conditions
2 sponsors
1 location
NCT04313140
Virtual Biopsy Development to Identify Patient's Glioma Grade at the CHU of Poitiers Using Magnetic Resonance Imaging
NA
Recruiting
500 participants
Started: Feb 22, 2021 · Completed: Jun 30, 2026
5 conditions
1 sponsor
1 location
NCT04696809
A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
40 participants
Started: Feb 22, 2021 · Completed: Apr 22, 2026
1 condition
1 sponsor
15 locations
NCT04690439
Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema
NA
Recruiting
104 participants
Started: Feb 22, 2021 · Completed: Feb 29, 2028
3 conditions
2 sponsors
2 locations
NCT04750798
An Observational Post-marketing Study Using Commercially Approved Biosense Webster (BWI) Medical Devices for the Treatment of Participants With Cardiac Arrhythmias
N/A
Recruiting
5,000 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2027
1 condition
1 sponsor
33 locations
NCT04524338
Longitudinal Study Examining At-Home tDCS
NA
Recruiting
20 participants
Started: Feb 22, 2021 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT04697628
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
PHASE3
Active, not recruiting
502 participants
Started: Feb 22, 2021 · Completed: May 7, 2026
1 condition
2 sponsors
217 locations
NCT06332937
Breast Reconstruction
N/A
Active, not recruiting
5,000 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04888741
Methods of T Cell Depletion Trial (MoTD)
PHASE2
Recruiting
400 participants
Started: Feb 22, 2021 · Completed: Jan 31, 2026
9 conditions
2 sponsors
15 locations
NCT04286191
Physiological Changes Induced Through MEP Conditioning in People With SCI
NA
Active, not recruiting
44 participants
Started: Feb 22, 2021 · Completed: Nov 30, 2025
4 conditions
2 sponsors
1 location
NCT04502719
Comparison of Nutritional Screening Tools in Liver Cirrhosis Patients
N/A
Recruiting
46 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT04750811
A Danish Audit of Small Bowel Obstruction
N/A
Active, not recruiting
540 participants
Started: Feb 22, 2021 · Completed: Mar 1, 2026
1 condition
1 sponsor
6 locations
NCT04688151
Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma.
PHASE1
Active, not recruiting
22 participants
Started: Feb 22, 2021 · Completed: Dec 31, 2025
1 condition
5 sponsors
1 location
NCT04713917
Evaluation of Innovative Therapeutic Approaches of Vaginal and Sexual Dysfunction After Breast Cancer Treatment
NA
Recruiting
330 participants
Started: Feb 21, 2021 · Completed: Feb 1, 2024
1 condition
4 sponsors
1 location
NCT04764682
Determining Molecular Drivers of Radiation Dermatitis
N/A
Active, not recruiting
20 participants
Started: Feb 21, 2021 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT03819296
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
PHASE1
Recruiting
800 participants
Started: Feb 21, 2021 · Completed: Oct 31, 2025
44 conditions
2 sponsors
1 location
NCT04080466
Cam Type FAI is a Cause of Hip Pain in the Young Adult and a Precursor to OA
PHASE2
Recruiting
58 participants
Started: Feb 20, 2021 · Completed: Jan 31, 2025
3 conditions
2 sponsors
1 location
NCT04777942
Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)
NA
Recruiting
320 participants
Started: Feb 20, 2021 · Completed: Dec 30, 2026
1 condition
1 sponsor
1 location
NCT04699773
LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
NA
Recruiting
32 participants
Started: Feb 20, 2021 · Completed: Dec 31, 2027
3 conditions
2 sponsors
5 locations
NCT06759142
Analysis of Patients With Autosomal Dominant Polycystic Kidney
N/A
Recruiting
180 participants
Started: Feb 20, 2021 · Completed: Jun 1, 2025
2 conditions
1 sponsor
1 location
NCT05370924
Assessment of the Development of Postoperative Persistent Postoperative Pain
N/A
Recruiting
600 participants
Started: Feb 20, 2021 · Completed: Jun 30, 2024
3 conditions
1 sponsor
1 location
NCT04844385
Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
PHASE2
Active, not recruiting
124 participants
Started: Feb 20, 2021 · Completed: Dec 20, 2024
1 condition
1 sponsor
1 location
NCT04832555
Non Elective Vulnerable Elderly Radiotherapy
NA
Recruiting
100 participants
Started: Feb 20, 2021 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT04076410
Efficacy of Lenses in Abolishing Photoparoxysmal Responses
NA
Active, not recruiting
28 participants
Started: Feb 20, 2021 · Completed: Jan 31, 2026
2 conditions
2 sponsors
2 locations
NCT04477512
Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)
PHASE1
Active, not recruiting
18 participants
Started: Feb 19, 2021 · Completed: Sep 11, 2025
1 condition
3 sponsors
1 location
NCT04556916
Early Detection of Prostate Cancer
NA
Recruiting
320 participants
Started: Feb 19, 2021 · Completed: Sep 15, 2033
1 condition
1 sponsor
4 locations
NCT04573192
A Study to Evaluate Safety and Efficacy of L19TNF Plus Lomustine in Patients With Glioblastoma at First Progression
PHASE1/PHASE2
Recruiting
142 participants
Started: Feb 19, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
15 locations
NCT04748601
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
PHASE4
Recruiting
132 participants
Started: Feb 19, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
15 locations
NCT04515836
Olaparib in Patients With HRD Malignant Mesothelioma
PHASE2
Recruiting
56 participants
Started: Feb 19, 2021 · Completed: Apr 15, 2028
2 conditions
2 sponsors
1 location
NCT04769960
Study of the Safety of MRI Scans in People Who Have Breast Tissue Expanders After Mastectomy
N/A
Active, not recruiting
68 participants
Started: Feb 19, 2021 · Completed: Feb 19, 2026
3 conditions
1 sponsor
3 locations
NCT06865209
Monolithic Zirconia Posterior Single Crowns: a Randomized Clinical Trial.
NA
Active, not recruiting
50 participants
Started: Feb 19, 2021 · Completed: Jan 9, 2026
1 condition
1 sponsor
1 location
NCT04699786
Returning Research Results That Indicate Risk of Alzheimer Disease Dementia to Healthy Participants in Longitudinal Studies
NA
Active, not recruiting
450 participants
Started: Feb 19, 2021 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT04782518
Personalizing Exercise for Parkinson Disease
N/A
Active, not recruiting
257 participants
Started: Feb 19, 2021 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT04747236
Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
PHASE2
Recruiting
50 participants
Started: Feb 19, 2021 · Completed: Jun 2, 2030
1 condition
2 sponsors
5 locations
NCT04575402
Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients
N/A
Active, not recruiting
40 participants
Started: Feb 19, 2021 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT04326192
Brown Adipose Tissue Activation by Spinal Cord Stimulation
NA
Recruiting
10 participants
Started: Feb 19, 2021 · Completed: Oct 31, 2026
3 conditions
1 sponsor
1 location
NCT04800159
Cannabis Effects on Antiretroviral Therapy Pharmacokinetics and Neurotoxicity
PHASE2
Active, not recruiting
40 participants
Started: Feb 19, 2021 · Completed: Apr 30, 2026
2 conditions
2 sponsors
1 location
Previous
1
More pages
1958
1959
1960
1961
1962
1963
1964
More pages
2369
Next